Overcoming Resistance to Temozolomide in Glioblastoma: A Scoping Review of Preclinical and Clinical Data
Article in Life (May 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Article in Journal of Hematology & Oncology (May 2024)
VIM-AS1, regulated by CpG methylation, cooperates with IGF2BP1 to inhibit tumor aggressiveness via EPHA3 degradation in hepatocellular carcinoma
Preprint in Research Square (April 2024)